fda ruling on tirzepatide today says shortage of GLP-1 drug is over FDA Ban on Compounded GLP-1

26, 2026: When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as a high-stakes patent fight over semaglutide and what it could mean for the broader multi-billion-dollar market for GLP-1 treatments

It also has the most adults suffering from diabetes after China, according to the International Diabetes Federation

Translational Psychiatry 5.CrossRefGoogle Scholar Tuesta, LM, Chen, Z, Duncan, A, Fowler, CD, Ishikawa, M, Lee, BR, Liu, XA, Lu, Q, Cameron, M, Hayes, MR and Kamenecka, TM (2017) GLP-1 acts on habenular avoidance circuits to control nicotine intake

PlexusDx sources all compounded medications exclusively from licensed 503A pharmacies, which operate under strict FDA oversight and quality standards

These vitamin injections rarely cause any side effects

Bowers et al